Clinical Conversations

Clinical Conversations

Download on the App Store

All Clinical Conversations episodes

  • Podcast 104: Reassurance on clopidogrel and omeprazole.

    We welcome Dr. Danielle Bowen Scheurer to our conversational team this week She’s a hospitalist at the Medical University of South Carolina and an associate editor of Physician’s First Watch.

    Our guest is Dr. Deepak Bhatt, who has just published some reassuring results on omeprazole’s putative interaction with clopidogrel in the New England Journal of Medicine.

    If you’d like to suggest topics or ways to improve this podcast, we’re all ears. Drop me a line at [email protected] — thank you.

    Interview-related link:

    • New England Journal of Medicine article (free)
    • News-related links:

      • Vaccine matchup looks good — MMWR article (free)
      • Low Apgar scores and cerebral palsy risk — BMJ article (free)
      • Screening survivors of childhood cancer — Annals abstract (free)
      • COG screening guidelines (free)
      • The post Podcast 104: Reassurance on clopidogrel and omeprazole. first appeared on Clinical Conversations.
        14 min
      • Podcast 103: eGFR and cardiovascular risk assessment

        Welcome back. We take a look this week at a study from Iceland that looks at whether estimated glomerular filtration rates have a role in estimating cardiovascular risk. Our interview is with Cambridge University’s Dr. Emanuele Di Angelantonio.

        Your comments are welcome, both here and to my email address: [email protected].

        Interview-related links:

        • BMJ study (free)
        • BMJ meta-analysis (free)
        • BMJ editorial (subscription needed)
        • News-related links:

          • ADHD story in Physician’s First Watch
          • Archives of Disease in Childhood (abstract)
          • MMWR (free)
          • Annals of Family Medicine (free full text)
          • The post Podcast 103: eGFR and cardiovascular risk assessment first appeared on Clinical Conversations.
            13 min
          • Podcast 102: Short compression stockings would seem to have no further role clinically.

            Prof. Martin Dennis chats with us about his latest trial, comparing the utility of thigh- versus below-knee-length stockings for patients immobilized after stroke. The latest results show the superiority of thigh-length stockings, but at the further risk of skin breaks in these vulnerable patients. Taken together with the results of his earlier work, at the very least the use of below-knee-length compression stockings — now widely used in patients undergoing surgery — must be called into question.

            Interview-related links:

            • Clinical Conversation’s earlier interview with Prof. Dennis.
            • Full text of the latest trial in Annals of Internal Medicine (free)
            • News-related links:

              • Avandia (rosiglitazone) restricted in Europe and the U.S.
              • Mammography’s modest contribution to lowering breast cancer mortality
              • New MS drug, fingolimod, approved by FDA
              • The post Podcast 102: Short compression stockings would seem to have no further role clinically. first appeared on Clinical Conversations.
                11 min
              • Podcast 101: Osteoarthritis, chondroitin, and glucosamine — one of these things doesn’t belong.

                Answer: Osteoarthritis. Two are nostrums and the other is a disease, but the nostrums have no appreciable effect — on osteoarthritis at least. We discuss a BMJ meta-analysis that uses novel methods to prove the point.

                The good news is that neither chondroitin nor glucosamine is dangerous, but the bad news is that we spend so much hoping that this is the right combination to alleviate arthritic pain.

                Interview related link:

                • BMJ meta-analysis
                • News-related links:

                  • PSA screening overdiagnoses prostate cancer and doesn’t lower mortality
                  • A distinct phenotype of chronic obstructive pulmonary disease
                  • New resistance factor, NDM-1, shows up in North America
                  • The post Podcast 101: Osteoarthritis, chondroitin, and glucosamine — one of these things doesn’t belong. first appeared on Clinical Conversations.
                    14 min
                  • Podcast 100: Practical informed consent

                    We’re not talking about philosophy here, but practical clinical approaches to making sure your patients understand what they’re agreeing to, and have the information to ask the right questions before they sign that form.

                    It’s podcast 100. I’m always looking for ways to make this useful, and if you have any reactions, please drop a line to [email protected]. Thank you!

                    Interview-related links:

                    • Dr. Fernandez’s editorial
                    • Annals study abstract
                    • Link to an organization providing patient decision aids
                    • News-related links:

                      • American Academy of Pediatrics proposal on mandatory flu shots for health workers
                      • Lancet abstract for the carotid stenosis study
                      • Lancet abstract on intimate-partner violence
                      • The post Podcast 100: Practical informed consent first appeared on Clinical Conversations.
                        20 min
                      • Podcast 99: Blacks’ higher rate of stent thrombosis apparently has a genetic basis.

                        It was thought that the increased risk among blacks undergoing stenting had to do with factors such as comorbid conditions and socioeconomics. But in a study in Circulation, their rate of stent thrombosis was higher than non-blacks, even after adjusting for those factors (and despite the fact that as a group, black were more adherent to their clopidogrel regimens).

                        We discuss things with the paper’s senior author, Dr. Ron Waksman.

                        Interview-related links:

                        • Circulation abstract
                        • Physician’s First Watch summary
                        • News-related links:

                          • Sibutramine abstract in NEJM
                          • ASCO guidelines on genetic screening
                          • JAMA article on risk-reducing surgeries
                          • PNAS article on chronic fatigue link to virus
                          • The post Podcast 99: Blacks’ higher rate of stent thrombosis apparently has a genetic basis. first appeared on Clinical Conversations.
                            11 min
                          • Podcast 98: Leafy green vegetables apparently lower one’s risks for type 2 diabetes

                            Our interview this week is with a research nutritionist whose BMJ meta-analysis found a 14% reduction in risk for type 2 diabetes among those with the highest intake (versus those with the lowest) of leafy green vegetables. It’s a meta-analysis, and not a randomized controlled trial, and it’s interesting. Listen in.

                            We’re off next week, so I’ll see you again in early September.

                            Interview-related links:

                            • Phyician’s First Watch summary
                            • BMJ article
                            • News-related links:

                              • Label information for “ella” 5-days-after emergency contraception
                              • FDA announcement of intent to withdraw approval from midodrine
                              • Neurology abstract on headaches in teens and possible lifestyle triggers
                              • The post Podcast 98: Leafy green vegetables apparently lower one’s risks for type 2 diabetes first appeared on Clinical Conversations.
                                12 min
                              • Podcast 97: What happens when vena cava filters break?

                                Vena cava filters, often meant to be permanent, can actually lose a strut or two. And it’s not as rare an occurrence as you might think. Our conversationalist found it happens about 15% of the time with a certain brand of filter. The FDA has announced that it’s starting its own studies of the problem. Listen in.

                                If you see something during the week that you’d like me to devote an interview to, please let me know. My email is [email protected]. I’d love to have your suggestions.

                                Interview-related links:

                                • FDA’s announcement on MedWatch
                                • Physician’s First Watch coverage of the vena cava filter research
                                • Study posted on the Bard website
                                • News-related links:

                                  • Abstract of study linking acetaminophen use to asthma in adolescents
                                  • Lancet Infectious Diseases report on new resistance factor in enterobacteria
                                  • Archives of Neurology report on protein signature of Alzheimer’s in spinal fluid
                                  • The post Podcast 97: What happens when vena cava filters break? first appeared on Clinical Conversations.
                                    19 min
                                  • Podcast 96: Survivors of childhood cancer face manageable reproductive risks.

                                    What becomes of children who survive cancer treatment and enter their reproductive years? Would their attempts to have children end in a higher-than-normal rate of stillbirths and miscarriages? Apparently not.

                                    It turns out the major concern is with women who’ve undergone pelvic irradiation before menarche. That treatment seems to hobble uterine development, but not irretrievably. For their part, boys who’ve had gonadal irradiation seem not to place their offspring at higher risk for adverse birth outcomes.

                                    Our conversation is with the senior author on a Lancet paper from last week investigating these effects.

                                    Interview-related links:

                                    • Physician’s First Watch summary
                                    • Abstract of Lancet article
                                    • News-related links:

                                      • Background material on FDA advisory committee vote
                                      • New York Times article on GlaxoSmithKline
                                      • Compression-only CPR
                                      • Caffeine in pregnancy
                                      • Mayo Clinic’s caffeine table
                                      • The post Podcast 96: Survivors of childhood cancer face manageable reproductive risks. first appeared on Clinical Conversations.
                                        13 min
                                      • Podcast 95: What if hypertensive patients titrated their own drug dosages?

                                        This week’s interview is with the editorialist commenting on an exciting Lancet paper. The writer, Dr. Gbenga Ogedegbe, says that the work, in which patients with uncontrolled hypertension titrated their own medications according to prespecified rules, could change how clinicians manage uncomplicated hypertension. From his base at New York University School of Medicine, Dr. Ogedegbe sees promise — if the costs are right. Listen in.

                                        Interview-related link:

                                        • Lancet paper (free abstract)
                                        • Dr. Ogedegbe’s editorial (you’ll need a Lancet subscription)
                                        • News-related links:

                                          • New VA rules on PTSD compensation
                                          • Back pain and glucosamine
                                          • Tight BP control in diabetics with coronary disease
                                          • The post Podcast 95: What if hypertensive patients titrated their own drug dosages? first appeared on Clinical Conversations.
                                            12 min